BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26334134)

  • 21. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
    [No Abstract]   [Full Text] [Related]  

  • 22. Single PA mutation as a high yield determinant of avian influenza vaccines.
    Lee I; Il Kim J; Park S; Bae JY; Yoo K; Yun SH; Lee JY; Kim K; Kang C; Park MS
    Sci Rep; 2017 Jan; 7():40675. PubMed ID: 28084423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules.
    Harvey R; Nicolson C; Johnson RE; Guilfoyle KA; Major DL; Robertson JS; Engelhardt OG
    Vaccine; 2010 Nov; 28(50):8008-14. PubMed ID: 20934460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoonotic influenza viruses: antigenic and genetic characteristics and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2017 Mar; 92(12):129-44. PubMed ID: 28337863
    [No Abstract]   [Full Text] [Related]  

  • 26. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.
    Legastelois I; Garcia-Sastre A; Palese P; Tumpey TM; Maines TR; Katz JM; Vogel FR; Moste C
    Influenza Other Respir Viruses; 2007 May; 1(3):95-104. PubMed ID: 19453414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective.
    Liu Y; Fu C; Ye S; Liang Y; Qi Z; Yao C; Wang Z; Wang J; Cai S; Tang S; Chen Y; Li S
    Vet Microbiol; 2021 Mar; 254():108997. PubMed ID: 33524810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric neuraminidase and mutant PB1 gene constellation improves growth and yield of H5N1 vaccine candidate virus.
    Plant EP; Ye Z
    J Gen Virol; 2015 Apr; 96(Pt 4):752-755. PubMed ID: 25502649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.
    Kim EH; Kwon HI; Park SJ; Kim YI; Si YJ; Lee IW; Kim SM; Kim SI; Ahn DH; Choi YK
    J Microbiol Biotechnol; 2018 Jun; 28(6):997-1006. PubMed ID: 29642288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content.
    Abt M; de Jonge J; Laue M; Wolff T
    Vaccine; 2011 Jul; 29(32):5153-62. PubMed ID: 21624413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.
    Johnson A; Chen LM; Winne E; Santana W; Metcalfe MG; Mateu-Petit G; Ridenour C; Hossain MJ; Villanueva J; Zaki SR; Williams TL; Cox NJ; Barr JR; Donis RO
    PLoS One; 2015; 10(6):e0128982. PubMed ID: 26068666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic and genetic characterization of influenza viruses isolated in Mozambique during the 2015 season.
    Tivane A; Daniels R; Nguenha N; Machalele L; Nacoto A; Pale M; Mateonane E; Mavale S; Chilundo J; Muteto D; Salência J; Albati F; Gudo E; Mussá T; McCauley J
    PLoS One; 2018; 13(7):e0201248. PubMed ID: 30048502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
    Lee YH; Jang YH; Seong BL
    Virology; 2017 Apr; 504():73-78. PubMed ID: 28157547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized clade 2.3.2.1c H5N1 recombinant-vaccine strains against highly pathogenic avian influenza.
    Jang JW; Lee CY; Kim IH; Choi JG; Lee YJ; Yuk SS; Lee JH; Song CS; Kim JH; Kwon HJ
    J Vet Sci; 2017 Aug; 18(S1):299-306. PubMed ID: 28859269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
    Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
    Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommended composition of influenza virus vaccines for use in the 2016–2017 northern hemisphere influenza season.
    Wkly Epidemiol Rec; 2016 Mar; 91(10):121-32. PubMed ID: 26971356
    [No Abstract]   [Full Text] [Related]  

  • 39. pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.
    Gerlach T; Hensen L; Matrosovich T; Bergmann J; Winkler M; Peteranderl C; Klenk HD; Weber F; Herold S; Pöhlmann S; Matrosovich M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28356532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.